XML 41 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Net sales $ 469,961 $ 530,644 $ 1,448,884 $ 1,576,820
Cost of goods sold 206,509 242,068 635,729 715,713
Gross profit 263,452 288,576 813,155 861,107
Selling, general and administrative expense 187,445 202,550 568,845 600,663
Research and Development Expense 43,336 52,786 137,085 161,046
Segment profit (loss) 32,671 33,240 107,225 99,398
Interest expense 5,822 7,710 15,658 17,131
Foreign exchange losses, net 2,166 3,667 8,910 6,118
Other (income) expense, net (732) (613) (8,992) (9,662)
Income before income taxes 25,415 22,476 91,649 85,811
Provision for income taxes (8,045) (10,967) (28,038) (36,003)
Net income including noncontrolling interests 17,370 11,509 63,611 49,808
Net income attributable to Bio-Rad $ 17,370 $ 11,509 $ 63,611 $ 49,808
Basic earnings per share:        
Net income per share basic attributable to Bio-Rad $ 0.59 $ 0.40 $ 2.18 $ 1.73
Weighted average common shares - basic 29,195 28,884 29,141 28,834
Diluted earnings per share:        
Net income per share diluted attributable to Bio-Rad $ 0.59 $ 0.39 $ 2.17 $ 1.71
Weighted average common shares - diluted 29,439 29,141 29,372 29,097